Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03601936 · ClinicalTrials.gov registry record · NA
User Testing of the Evivo Screening Test
A NA study, sponsored by Evolve BioSystems.
- Terminated
- Registry status
- NA
- Development phase
- 231
- Enrollment target
NCT03601936 is a NA study that was terminated before completion, run by Evolve BioSystems. The registered enrollment target is 231 participants.
The verdict
NCT03601936, a NA study, was terminated before completion, sponsored by Evolve BioSystems.
- TERMINATED
- Registry status
- NA
- Development phase
- 231 participants
- Enrollment target
Study Summary
The study is an evaluation of the Evivo Screening Test's ability to differentiate between high and low levels of Bifidobacterium in infant stool specimens.
Interventions
- DEVICE Evivo Infant Gut Bifidobacterium Screening Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 231 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2019-04-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03601936
The ClinicalTrials.gov registry entry for NCT03601936 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 231 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Evolve BioSystems, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Evivo Infant Gut Bifidobacterium Screening Test is the first listed.
NCT03601936 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03601936 about?
NCT03601936 is a clinical study titled "User Testing of the Evivo Screening Test". The study is an evaluation of the Evivo Screening Test's ability to differentiate between high and low levels of Bifidobacterium in infant stool specimens.
What is the current status of trial NCT03601936?
This trial is currently terminated. It is a NA study. The enrollment target is 231 participants. The study started on 2018-08-01. Estimated completion is 2019-04-24.
What interventions are being tested in trial NCT03601936?
The interventions under investigation include: Evivo Infant Gut Bifidobacterium Screening Test (DEVICE).
Who is sponsoring clinical trial NCT03601936?
This trial is sponsored by Evolve BioSystems, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.